Ori Biotech

Ori Biotech is a developer of a manufacturing platform used to help patients get access to lifesaving treatments. Ori has developed a proprietary, flexible manufacturing platform that closes, automates, and standardizes manufacturing allowing therapeutics developers to further develop and bring their products from pre-clinical process development to commercial-scale manufacturing. The company aims to speed up the innovation of cell and gene therapies through the manufacturing platform it is bringing to market.

Ori Biotech headquartered in Europe, operates in the Biotechnology, Manufacturing, Therapeutics, Industrial Automation sector. The company focuses on Biotechnology and has secured $6.7B in funding across 48 round(s). With a team of 11-50 employees, Ori Biotech is actively contributing to advancements in Biotechnology. Their latest funding round, Series B - Ori Biotech, raised $100.0M. Discover more about their projects, partnerships, and impact on our platform.